Regarding HMOX1, we previously performed a similar analysis using these three databases, which revealed no significant differences in mRNA expression levels among tumoral and non-tumoral prostate tissue, but demonstrated that PCa patients with higher expression of HMOX1 showed longer RFS (HR: 0.5, p = 0.021) [36]. The gene discussed is HMOX1; the disease is posterior cortical atrophy.